Meet us at EHRA 2025, 30 March to 1 April in Vienna!
Infections occur in 1–4 % of all cardiac implantable electronic devices (CIED).
CIED infections lead to a staggering amount of incremental costs.
TauroPace™ reduces CIED infections without unwanted side effects.
TauroPharm
Newsletter
We'll keep you posted on upcoming events, free download materials, and research insights.
Our website uses cookies and Analytics to guarantee you the best possible user experience. You can find more information in our privacy policy.
